Study of ODX (OsteoDex) in Multiple Myeloma

Clinical trial NCT06616389 · RECRUITING

Trial details

NCT number: NCT06616389
Sponsor: DexTech Medical AB
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2023-11-29
Primary completion: 2026-01-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.